Fencamfamine modulates sodium, potassium-ATPase through cyclic AMP and cyclic AMP-dependent protein kinase in rat striatum M. Pinto FerreiraR. DeLuciaC. Scavone Pages: 549 - 560
Effects of buspirone on plasma neurotransmitters in healthy subjects F. LechinB. van der DijsA. Lechin Pages: 561 - 573
Characterization of the 5-HT4 binding site in human brain B. ArranzP. RoselJ. Marcusson Pages: 575 - 586
Effect of clobenpropit, a centrally acting histamine H3-receptor antagonist, on electroshock- and pentylenetetrazol-induced seizures in mice W. FischerH. van der Goot Pages: 587 - 599
Rimcazole, a sigma receptor ligand, and the anticonvulsive action of conventional antiepileptic drugs K. K. BorowiczP. M. WilczyńskiS. J. Czuczwar Pages: 601 - 612
Strong paired pulse depression of dentate granule cells in slices from patients with temporal lobe epilepsy T. H. SwansonM. R. SperlingM. J. O'Connor Pages: 613 - 625
Nitrite and nitrate levels in cerebrospinal fluid of normal subjects L. ZeccaM. RosatiR. G. Fariello Pages: 627 - 633
The silent and selective 5-HT1A antagonist, WAY 100635, produces via an indirect mechanism, a 5-HT2A receptor-mediated behaviour in mice during the day but not at night N. A. Darmani Pages: 635 - 643
Effects of various tetrahydroisoquinoline derivatives on mitochondrial respiration and the electron transfer complexes N. MorikawaM. NaoiY. Mizuno Pages: 677 - 688
Evaluation of neuronal loss, astrocytosis and abnormalities of cytoskeletal components of large motor neurons in the human anterior horn in aging F. F. Cruz-SánchezA. MoralM. L. Rossi Pages: 689 - 701
Cerebrospinal fluid levels of alpha-tocopherol in amyotrophic lateral sclerosis F. de BustosF. J. Jiménez-JiménezR. Enríquez de Salamanca Pages: 703 - 708
Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease M. N. SabbaghR. T. ReidL. J. Thal Pages: 709 - 717
Effects of the D3 and autoreceptor-preferring dopamine antagonist (+)-UH232 in schizophrenia A. C. LahtiM. WeilerC. A. Tamminga Pages: 719 - 734
Mazindol, nomifensine and desmethylimipramine inhibit potassium-induced release of dopamine: effect of stimulus strength D. Dembiec-Cohen Pages: 735 - 747
Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release P. A. BroderickM. F. Piercey Pages: 749 - 767